Despite the quantum of research on Stargardt’s disease, particularly the extensive studies on the disease associated variants present in the ABCA4 gene, an approved therapy for this disease is lacking and promising therapy remains elusive. This evidence concerns the gene ABCA4 and Stargardt disease.